Nirman Agri Genetics Board of Directors
Get the latest insights into the leadership at Nirman Agri Genetics. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Pranav Kailas Bagal | Managing Director |
| Mr. Avinash Bhimrao Bagal | Non Executive Director |
| Mr. Riddhi Nitin Aher | Independent Director |
| Mr. Prakash Narayandas Sawana | Independent Director |
| Mr. Abhishek Shivnarayan Gupta | Independent Director |
Nirman Agri Genetics Share price
NIRMAN
139.6
0.40 (-0.29%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High
142.90
Today's Low
139.00
52 Week Low
138.50
52 Week High
456.00
The current prices are delayed, login to your account for live prices
LoginNirman Agri Genetics FAQs
The board at Nirman Agri Genetics consists of experienced professionals, including Mr. Pranav Kailas Bagal , Mr. Avinash Bhimrao Bagal , and others, overseeing the company’s strategic and corporate governance.
Directors at Nirman Agri Genetics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Pranav Kailas Bagal is the current chairman at Nirman Agri Genetics.
Executive directors at Nirman Agri Genetics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Nirman Agri Genetics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Nirman Agri Genetics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.